Lexeo Therapeutics, Inc.·4

Jun 30, 5:00 PM ET

DIAZ REINALDO M 4

4 · Lexeo Therapeutics, Inc. · Filed Jun 30, 2025

Insider Transaction Report

Form 4
Period: 2025-06-26
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-26+25,00025,000 total
    Exercise: $4.18Exp: 2035-06-25Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]100% of the shares underlying the option shall vest, and become exercisable, on the earlier of June 26, 2026, or the date of the Issuer's next annual stockholders meeting, subject to the Reporting Person's continuous service on such date.

Documents

1 file
  • 4
    form4-06302025_050611.xmlPrimary